Discovery and Evaluation of C6-Substituted Pyrazolopyrimidine-Based Bisphosphonate Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase and Evaluation of Their Antitumor Efficacy in Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and Colorectal Cancer

Rebecca Boutin, Hiu-Fung Lee, Tian Lai Guan, Tan Trieu Nguyen, Xian Fang Huang, Daniel D. Waller, Jordan Lu, Iok In Christine Chio, René P. Michel, Michael Sebag and Youla S. Tsantrizos

J. Med. Chem., 2023, 66, 15776
DOI: 10.1021/acs.jmedchem.3c01271

Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) Technology

Michael Garrigou, Bérengère Sauvagnat, Ruchia Duggal, Nicole Boo, Pooja Gopal, Jennifer M. Johnston, Anthony Partridge, Tomi Sawyer, Kaustav Biswas and Nicolas Boyer

J. Med. Chem., 2022, 65, 8961
DOI: 10.1021/acs.jmedchem.2c00154

Dynamic regulation of RAS and RAS signaling

Walter Kolch, Dénes Berta and Edina Rosta

Biochemical Journal, 2023, 480, 1
DOI: 10.1042/BCJ20220234

Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1

Simon Ng, Alexander C. Brueckner, Soheila Bahmanjah, Qiaolin Deng, Jennifer M. Johnston, Lan Ge, Ruchia Duggal, Bahanu Habulihaz, Benjamin Barlock, Sookhee Ha, Ahmad Sadruddin, Constance Yeo, Corey Strickland, Andrea Peier, Brian Henry, Edward C. Sherer and Anthony W. Partridge

J. Med. Chem., 2022, 65, 9789
DOI: 10.1021/acs.jmedchem.2c00406

Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations

Minxia Michelle He, Sean Xiaochun Zhu, Joe R. Cannon, Jesper Kammersgaard Christensen, Ruchia Duggal, Mithat Gunduz, Constanze Hilgendorf, Adam Hughes, Ivy Kekessie, Maximilian Kullmann, Dennis Leung, Carsten Terjung, Kai Wang and Frank Wesche

Drug Metabolism and Disposition, 2023, 51, 1436
DOI: 10.1124/dmd.123.001437

Utilization of macrocyclic peptides to target protein-protein interactions in cancer

Jiawen Yang, Qiaoliang Zhu, Yifan Wu, Xiaojuan Qu, Haixia Liu, Biao Jiang, Di Ge and Xiaoling Song

Front. Oncol., 2022, 12
DOI: 10.3389/fonc.2022.992171

Rapid label-free cell-based Approach Membrane Permeability Assay using MALDI-hydrogen-deuterium exchange mass spectrometry for peptides

Alexey A. Makarov, Yuan Jiang, Christopher Sondey, Minjia Zhang, My Sam Mansueto, Gregory F. Pirrone, Chunhui Huang, Kaustav Biswas, Ruchia Duggal, Mohammad Ahmed Al-Sayah, Erik L. Regalado and Ian Mangion

Analytica Chimica Acta, 2022, 1225, 340234
DOI: 10.1016/j.aca.2022.340234

New prospectives on treatment opportunities in RASopathies

Bruce D. Gelb, Marielle E. Yohe, Cordula Wolf and Gregor Andelfinger

American J of Med Genetics Pt C, 2022, 190, 541
DOI: 10.1002/ajmg.c.32024

Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96

Randa Mahran, Jonas N. Kapp, Salla Valtonen, Allison Champagne, Jinying Ning, William Gillette, Andrew G. Stephen, Feng Hao, Andreas Plückthun, Harri Härmä, Tatu Pantsar and Kari Kopra

ACS Chem. Biol., 2024, 19, 2152
DOI: 10.1021/acschembio.4c00315

Peptides as multifunctional players in cancer therapy

Sri Murugan Poongkavithai Vadevoo, Smriti Gurung, Hyun-Su Lee, Gowri Rangaswamy Gunassekaran, Seok-Min Lee, Jae-Won Yoon, Yun-Ki Lee and Byungheon Lee

Exp Mol Med, 2023, 55, 1099
DOI: 10.1038/s12276-023-01016-x

Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists

Arun Chandramohan, Hubert Josien, Tsz Ying Yuen, Ruchia Duggal, Diana Spiegelberg, Lin Yan, Yu-Chi Angela Juang, Lan Ge, Pietro G. Aronica, Hung Yi Kristal Kaan, Yee Hwee Lim, Andrea Peier, Brad Sherborne, Jerome Hochman, Songnian Lin, Kaustav Biswas, Marika Nestor, Chandra S. Verma, David P. Lane, Tomi K. Sawyer, Robert Garbaccio, Brian Henry, Srinivasaraghavan Kannan, Christopher J. Brown, Charles W. Johannes and Anthony W. Partridge

Nat Commun, 2024, 15
DOI: 10.1038/s41467-023-43346-4

Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics

Colin S. Swenson, Gunasheil Mandava, Deborah M. Thomas and Raymond E. Moellering

Chem. Rev., 2024, 124, 13020
DOI: 10.1021/acs.chemrev.4c00423

Peptide inhibitors targeting Ras and Ras-associated protein–protein interactions

Dan Han, Anpeng Li, Lie Zhu, Chunlin Zhuang, Qingjie Zhao and Yan Zou

European Journal of Medicinal Chemistry, 2024, 279, 116878
DOI: 10.1016/j.ejmech.2024.116878

Peptide inhibitors: Breaking cancer code

Fleur Coburn, Yanyamba Nsereko, Amy Armstrong and Othman Al Musaimi

European Journal of Medicinal Chemistry, 2025, 297, 117961
DOI: 10.1016/j.ejmech.2025.117961

Strategic applications of methylene thioacetal bonds as disulfide surrogates in peptide drug discovery

Yaqi Zhou, Dongyuan Wang, Jiean Xu and Nan Zheng

Front. Chem., 2025, 13
DOI: 10.3389/fchem.2025.1637329

Affinity selection–mass spectrometry with linearizable macrocyclic peptide libraries

Michael A. Lee, Joseph S. Brown, Charlotte E. Farquhar, Andrei Loas and Bradley L. Pentelute

Sci. Adv., 2025, 11
DOI: 10.1126/sciadv.adr1018

CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells

Alyssa N. Werner, Avani I. Kumar, Pascale G. Charest and Matthew Welch

MBoC, 2023, 34
DOI: 10.1091/mbc.E23-05-0152